We are live on
!
Find out more
STI
Susquehanna Trust & Investment Portfolio holdings
AUM
$457M
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+0.73%
1 Year Est. Return
+0.8%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$426M
AUM Growth
–
Cap. Flow
+$432M
Cap. Flow
% of AUM
101.59%
Top 10 Holdings %
Top 10 Hldgs %
31.73%
Holding
91
New
91
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$16.8M |
| 2 |
Pfizer
PFE
|
+$16.2M |
| 3 |
GE Aerospace
GE
|
+$14.6M |
| 4 |
Merck
MRK
|
+$13.1M |
| 5 |
AT&T
T
|
+$12.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.6% |
| 2 | Technology | 16.4% |
| 3 | Consumer Staples | 14.63% |
| 4 | Industrials | 10.51% |
| 5 | Financials | 8.61% |
Similar funds
CG
HC
SCVF
GMCM
RRC
F
R
SBK
Susquehanna Trust & Investment's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Susquehanna Trust & Investment, which disclosed 91 positions worth $426M. Its ten largest holdings account for 32% of the portfolio.
Its largest position is Johnson & Johnson: 197,948 shares worth $17M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, followed by Technology and Consumer Staples.
- Susquehanna Trust & Investment's largest Q2 2013 buy was Johnson & Johnson: 197,948 shares worth $17M.
- Susquehanna Trust & Investment's ten largest holdings make up 32% of its $426M portfolio in Q2 2013.
- Susquehanna Trust & Investment disclosed 91 positions in Q2 2013, its first 13F filing on record.
Based on Susquehanna Trust & Investment's 13F filing for Q2 2013, filed 25 Jul 2013.